Concepedia

Tmax Comparison

Tmax Comparison is a pharmacokinetic metric used in the bioequivalence assessment of modified-release products that quantifies the difference in the time to reach peak plasma concentration between test and reference formulations, distinguishing it from other bioequivalence measures by its focus on the rate of drug absorption rather than extent or overall exposure.

33

Publications

1.2K

Citations

171

Authors

66

Institutions

Publications per year

2017–2026

3

Parents

Publications

33

Maximum Life Span Predictions From the Gompertz Mortality Model

Caleb E. Finch, Malcolm C. Pike · The Journals of Gerontology Series A · 1996 · 155 citations

, , +11

Pharmacokinetics and Pharmacodynamics of the Novel Daily Rivastigmine Transdermal Patch Compared With Twice-daily Capsules in Alzheimer's Disease Patients

Gilbert Lefèvre, G Sędek, S. S. Jhee et al. · Clinical Pharmacology & Therapeutics · 2007 · 130 citations · Full text

, , +17

Significant Strength Gains Observed in Rugby Players after Specific Resistance Exercise Protocols Based on Individual Salivary Testosterone Responses

C. Martyn Beaven, Christian J. Cook, Nicholas D. Gill · The Journal of Strength and Conditioning Research · 2008 · 80 citations

, , +17

Effect of Eleutherococcus senticosus on submaximal and maximal exercise performance

E. Dowling, D. Redondo, John Branch et al. · Medicine & Science in Sports & Exercise · 1996 · 78 citations

, , +17

Pharmacokinetics and relative bioavailability of fentanyl pectin nasal spray 100 – 800 µg in healthy volunteers

Alexander Fisher, Mark Watling, Alexandra A. Smith et al. · International Journal of Clinical Pharmacology and Therapeutics · 2010 · 64 citations

, , +17

1–5 of 33

Authors

171

  1. PD
    Philippe Danjou

    Structure Fédérative de Recherche en Biologie et Santé de Rennes, France

    2 publications · 58 citations

    2

    h-index

  2. AP
    A. P. F. Flint

    Institute of Animal Physiology of the Slovak Academy of Sciences, Slovakia

    2 publications · 58 citations

    2

    h-index

  3. PG
    Per G. Djupesland

    OptiNose (Norway), Norway

    2 publications · 58 citations

    2

    h-index

  4. RL
    R. Luthringer

    Centre hospitalier de Rouffach, France

    2 publications · 58 citations

    2

    h-index

  5. CD
    Colin D Sheldrake

    Centre hospitalier de Rouffach, France

    2 publications · 58 citations

    2

    h-index

1–5 of 171

Institutions

66

  1. Centre hospitalier de Rouffach

    Rouffach, France

    2 h-index

    5 publications

    202 citations

  2. Shenyang Pharmaceutical University

    Shenyang, China

    1 h-index

    1 publications

    11 citations

  3. Shanxi University

    Taiyuan, China

    1 h-index

    6 publications

    282 citations

  4. Volgograd Regional Clinical Oncology Center

    Volgograd, Russia

    1 h-index

    1 publications

    14 citations

  5. S. M. Kirov Military Medical Academy

    St Petersburg, Russia

    1 h-index

    1 publications

    14 citations

  6. BIOCAD (Russia)

    Strel'na, Russia

    1 h-index

    2 publications

    28 citations

  7. Russian Cancer Research Center NN Blokhin

    Moscow, Russia

    1 h-index

    1 publications

    14 citations

  8. Bayer (Germany)

    Leverkusen, Germany

    1 h-index

    1 publications

    26 citations

1–8 of 66

Venues

  1. PubMed

    Repository · 4 publications · 70 citations

    4

    h-index

  2. Journal of Pharmacy and Pharmacology

    JPP · 2 publications · 58 citations

    2

    h-index

  3. British Journal of Clinical Pharmacology

    BJCP · 2 publications · 80 citations

    2

    h-index

  4. Medicine & Science in Sports & Exercise

    MSSE · 1 publications · 78 citations

    1

    h-index

  5. Clinical Pharmacology & Therapeutics

    CPT · 1 publications · 130 citations

    1

    h-index

1–5